HLL’s corporate R&D Centre is focussed to carry out multi-disciplinary research and development aimed at creating scientific knowledge for new technology development and value addition of existing technologies in the healthcare field.
Through the interchange of creative, imaginative people, a global Research and Development (R&D) centre, that encourages collaboration and cooperation among highly reputed research centres in the country; and as a strong commitment to ongoing investment, we have put R&D at the centre of everything we do.
We accomplish this integration by forming multi-disciplinary teams that work cohesively, monitoring projects continuously and proactively addressing and resolving critical issues.
Our philosophy in the Synthetic Organic Chemistry Laboratory is to provide the best possible solutions, through the study on organic synthesis, abilities to (1) understand one another’s research need, (2) make independent, logical research plans, and (3) consider and evaluate obtained results accurately to achieve the need. We accept exclusive and confidential research projects for the development of New Chemical Entity (NCE) and process development for existing drug molecules. We are well experienced in providing medicinal chemistry, multi-step synthetic organic chemistry, heterocyclic, and achiral synthesis. Our broad service offering leverages our innovative synthetic chemistry expertise to support the custom research requirements of our international business partners.
The core function of the Medical device division is to accelerate interdisciplinary medical device research and development. This division focuses on the development of products like implants, drug delivery systems, nanomaterials, prophylactics etc.
Pharmaceutics and Drug Delivery Division focuses on development of NCE formulations, Generic formulations, novel products with an objective to introduce better patient compliance. Pharma Division has the state of art infrastructure to develop various dosage forms.
We work on our development strategy based on in-depth study of patents, scientific literature, critical quality attributes (CQA) and quality target product profiles (QTPP) of the respective drug delivery system.
The natural products division is capable of developing new herbal formulations for various ailments including vaginal candidiasis, uterine disorders, PCOS, Sexually Transmitting Infections (STIs) like HIV/AIDS etc.
The Diagnostic division offers a comprehensive menu covering application in Molecular biology, Microbiology, Immunology and Molecular Genetics. The division is concerned with early and accurate detection of a medical condition, which can lead to effective medical treatment.